Venture Debt in Europe: Opportunity Missed?
This article was originally published in Start Up
Executive Summary
European biotechs may bemoan their funding disadvantages relative to US counterparts, but perhaps it's in part because they're not seizing alternative funding options available to them--like venture debt, for instance.